CGP-35348

CGP-35348
Systematic (IUPAC) name
3-aminopropyl(diethoxymethyl)phosphinic acid
Identifiers
CAS Number 123690-79-9 YesY
PubChem CID 107699
IUPHAR/BPS 1069
ChemSpider 96869 N
Chemical data
Formula C8H20NO4P
Molar mass 225.222 g/mol
 NYesY (what is this?)  (verify)

CGP-35348 is a compound used in scientific research which acts as an antagonist at GABAB receptors.[1][2][3]

CGP-35348 was ineffective up to 100 μM to antagonice the inhibitory release of GABA elicited by baclofen, doing it selective as GABAB heteroreceptor antagonist. [4] Moreover, CGP35348 was about threefold less potent to antagonize GHB and GBL than baclofen and SKF97541. [5]


References

  1. Carter LP, Chen W, Coop A, Koek W, France CP (May 2006). "Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348". European Journal of Pharmacology 538 (1-3): 85–93. doi:10.1016/j.ejphar.2006.03.039. PMID 16647701.
  2. Nasrallah FA, Griffin JL, Balcar VJ, Rae C (August 2007). "Understanding your inhibitions: modulation of brain cortical metabolism by GABA(B) receptors". Journal of Cerebral Blood Flow and Metabolism 27 (8): 1510–20. doi:10.1038/sj.jcbfm.9600453. PMID 17293844.
  3. Koek W, Mercer SL, Coop A, France CP (September 2009). "Behavioral effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348)". The Journal of Pharmacology and Experimental Therapeutics 330 (3): 876–83. doi:10.1124/jpet.109.151845. PMC: 2729800. PMID 19564487.
  4. Maurizio Raiteri. "Functional Pharmacology in Human Brain". doi:10.1124/pr.58.2.5.
  5. Koek W1, Mercer SL, Coop A. "Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348.".



This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.